Stockscreener 앱 받기
58.21
2.71%
-1.62
Vaxcyte Inc 주식(PCVX)의 최신 뉴스
Why (PCVX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Vaxcyte to Participate in Upcoming Investor Conferences - Investing News Network
Vaxcyte Inc develops next-generation vaccines as interest in pneumococcal prevention grows - ad-hoc-news.de
Should Early VAX-A1 Trial Progress Require Action From Vaxcyte (PCVX) Investors? - simplywall.st
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock By Investing.com - Investing.com Australia
Vaxcyte president and CFO sells $572k in company stock - Investing.com
Form 4 Vaxcyte Inc For: 6 July By Investing.com - Investing.com Nigeria
[Form 4] Vaxcyte, Inc. Insider Trading Activity - Stock Titan
Vaxcyte COO Jim Wassil sells $126,736 in PCVX shares - Investing.com
Vaxcyte (PCVX) COO logs 2,250-share sale and option exercise in Form 4 - Stock Titan
Affiliate plans 10,000-share sale by option exercise — PCVX - Stock Titan
Vaxcyte, Inc. (PCVX) Stock Analysis: Biotechnology Innovator with an 86.68% Potential Upside - DirectorsTalk Interviews
PCVXVaxcyte Inc Volatility & Greeks - Finviz
Vaxcyte stock stays tied to pipeline progress. Nasdaq listing and SEC filings frame the setup. - ad-hoc-news.de
Vaxcyte Inc (PCVX) Is A Hidden Multibagger Stock To Buy Now - Yahoo Finance
Have Insiders Sold Vaxcyte Shares Recently? - simplywall.st
Form 144 Vaxcyte For: 1 July By Investing.com - Investing.com Canada
PCVX (NASDAQ) director reported three 2,250-share sales and RSU/option items - Stock Titan
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Growth Benchmark - marketscreener.com
10 Health Care Stocks With Whale Alerts In Today’s Session - Benzinga
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2000 Growth Benchmark - marketscreener.com
Vaxcyte, Inc. (PCVX) Stock Analysis: Exploring a Potential 92.85% Upside in the Biotech Sector - DirectorsTalk Interviews
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 3000E Growth Benchmark - marketscreener.com
Vaxcyte Insider Sold Shares Worth $1,338,270, According to a Recent SEC Filing - marketscreener.com
Is Vaxcyte’s (PCVX) Russell Index Debut Quietly Reframing Its Long‑Term Governance And Growth Story? - simplywall.st
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Understanding Momentum Shifts in (PCVX) - Stock Traders Daily
Enterprise value to EBIT forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Price to book forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Enterprise value to EBIT forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to sales forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Enterprise value to revenue forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to earnings forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Enterprise value to EBITDA forward of Vaxcyte, Inc. – NASDAQ:PCVX - TradingView
Price to earnings forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Price to book forward of Vaxcyte, Inc. – XETR:5VA - TradingView
Vaxcyte CEO Grant Pickering sells $1.34m in company shares By Investing.com - Investing.com India
Vaxcyte CEO Grant Pickering sells $1.34m in company shares - Investing.com UK
Form 144 Vaxcyte For: 26 June By Investing.com - Investing.com South Africa
Form 4 Vaxcyte Inc For: 26 June By Investing.com - Investing.com Nigeria
Vaxcyte (PCVX) CEO and family trusts sell 24,237 shares under 10b5-1 plan - Stock Titan
PCVX Forecast — Price Target — Prediction for 2027 - TradingView
2.64%
자본화:
|
볼륨(24시간):